331 related articles for article (PubMed ID: 32701552)
1. Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer Perspective.
Oh M; Patanwala AE; Alkhatib N; Almutairi A; Abraham I; Erstad B
Crit Care Med; 2020 Oct; 48(10):e906-e911. PubMed ID: 32701552
[TBL] [Abstract][Full Text] [Related]
2. Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.
Heming N; Renault A; Kuperminc E; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Leone M; Timsit JF; Misset B; Benali MA; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Bounab R; Maxime V; Moine P; Bellissant E; Annane D; ;
Lancet Respir Med; 2024 May; 12(5):366-374. PubMed ID: 38310918
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of adjunctive corticosteroids for patients with septic shock.
Thompson KJ; Taylor CB; Venkatesh B; Cohen J; Hammond NE; Jan S; Li Q; Myburgh J; Rajbhandari D; Saxena M; Kumar A; Finfer SR;
Crit Care Resusc; 2020 Sep; 22(3):191-199. PubMed ID: 32900325
[TBL] [Abstract][Full Text] [Related]
4. Hydrocortisone Therapy in Catecholamine-Resistant Pediatric Septic Shock: A Pragmatic Analysis of Clinician Practice and Association With Outcomes.
Nichols B; Kubis S; Hewlett J; Yehya N; Srinivasan V
Pediatr Crit Care Med; 2017 Sep; 18(9):e406-e414. PubMed ID: 28658197
[TBL] [Abstract][Full Text] [Related]
5. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.
Annane D; Sébille V; Charpentier C; Bollaert PE; François B; Korach JM; Capellier G; Cohen Y; Azoulay E; Troché G; Chaumet-Riffaud P; Bellissant E
JAMA; 2002 Aug; 288(7):862-71. PubMed ID: 12186604
[TBL] [Abstract][Full Text] [Related]
6. The ADRENAL study protocol: adjunctive corticosteroid treatment in critically ill patients with septic shock.
Venkatesh B; Myburgh J; Finfer S; Webb SA; Cohen J; Bellomo R; McArthur C; Joyce CJ; Rajbhandari D; Glass P; Harward M;
Crit Care Resusc; 2013 Jun; 15(2):83-8. PubMed ID: 23931038
[TBL] [Abstract][Full Text] [Related]
7. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.
Annane D; Renault A; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Martin C; Timsit JF; Misset B; Ali Benali M; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Amathieu R; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Maxime V; Bellissant E;
N Engl J Med; 2018 Mar; 378(9):809-818. PubMed ID: 29490185
[TBL] [Abstract][Full Text] [Related]
8. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Fujii T; Luethi N; Young PJ; Frei DR; Eastwood GM; French CJ; Deane AM; Shehabi Y; Hajjar LA; Oliveira G; Udy AA; Orford N; Edney SJ; Hunt AL; Judd HL; Bitker L; Cioccari L; Naorungroj T; Yanase F; Bates S; McGain F; Hudson EP; Al-Bassam W; Dwivedi DB; Peppin C; McCracken P; Orosz J; Bailey M; Bellomo R;
JAMA; 2020 Feb; 323(5):423-431. PubMed ID: 31950979
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.
Venkatesh B; Finfer S; Cohen J; Rajbhandari D; Arabi Y; Bellomo R; Billot L; Correa M; Glass P; Harward M; Joyce C; Li Q; McArthur C; Perner A; Rhodes A; Thompson K; Webb S; Myburgh J;
N Engl J Med; 2018 Mar; 378(9):797-808. PubMed ID: 29347874
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.
; Annane D; Cariou A; Maxime V; Azoulay E; D'honneur G; Timsit JF; Cohen Y; Wolf M; Fartoukh M; Adrie C; Santré C; Bollaert PE; Mathonet A; Amathieu R; Tabah A; Clec'h C; Mayaux J; Lejeune J; Chevret S
JAMA; 2010 Jan; 303(4):341-8. PubMed ID: 20103758
[TBL] [Abstract][Full Text] [Related]
11. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial.
Gordon AC; Mason AJ; Perkins GD; Stotz M; Terblanche M; Ashby D; Brett SJ
Crit Care Med; 2014 Jun; 42(6):1325-33. PubMed ID: 24557425
[TBL] [Abstract][Full Text] [Related]
12. Practice Patterns in the Initiation of Secondary Vasopressors and Adjunctive Corticosteroids during Septic Shock in the United States.
Bosch NA; Teja B; Wunsch H; Walkey AJ
Ann Am Thorac Soc; 2021 Dec; 18(12):2049-2057. PubMed ID: 33975530
[No Abstract] [Full Text] [Related]
13. Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial.
Sevransky JE; Rothman RE; Hager DN; Bernard GR; Brown SM; Buchman TG; Busse LW; Coopersmith CM; DeWilde C; Ely EW; Eyzaguirre LM; Fowler AA; Gaieski DF; Gong MN; Hall A; Hinson JS; Hooper MH; Kelen GD; Khan A; Levine MA; Lewis RJ; Lindsell CJ; Marlin JS; McGlothlin A; Moore BL; Nugent KL; Nwosu S; Polito CC; Rice TW; Ricketts EP; Rudolph CC; Sanfilippo F; Viele K; Martin GS; Wright DW;
JAMA; 2021 Feb; 325(8):742-750. PubMed ID: 33620405
[TBL] [Abstract][Full Text] [Related]
14. Fludrocortisone Plus Hydrocortisone Versus Hydrocortisone Alone as Adjunctive Therapy in Septic Shock: A Retrospective Cohort Study.
Lock AE; Gutierrez GC; Hand EO; Barthol CA; Attridge RL
Ann Pharmacother; 2023 Dec; 57(12):1375-1388. PubMed ID: 37026172
[TBL] [Abstract][Full Text] [Related]
15. Low-dose corticosteroids in septic shock: Has the pendulum shifted?
Lemieux SM; Levine AR
Am J Health Syst Pharm; 2019 Apr; 76(8):493-500. PubMed ID: 30851043
[TBL] [Abstract][Full Text] [Related]
16. Effect of hydrocortisone versus methylprednisolone on clinical outcomes in oncology patients with septic shock.
McDonnell E; Collins R; Hernandez M; Brown ART
J Oncol Pharm Pract; 2021 Jan; 27(1):54-62. PubMed ID: 32686618
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects of adding fludrocortisone to a hydrocortisone-based shock protocol in hypotensive critically ill children.
Hebbar KB; Stockwell JA; Fortenberry JD
Intensive Care Med; 2011 Mar; 37(3):518-24. PubMed ID: 21152900
[TBL] [Abstract][Full Text] [Related]
18. Early initiation of low-dose hydrocortisone treatment for septic shock in adults: A randomized clinical trial.
Lv QQ; Gu XH; Chen QH; Yu JQ; Zheng RQ
Am J Emerg Med; 2017 Dec; 35(12):1810-1814. PubMed ID: 28615145
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Machine Learning to Estimate the Individual Treatment Effect of Corticosteroids in Septic Shock.
Pirracchio R; Hubbard A; Sprung CL; Chevret S; Annane D;
JAMA Netw Open; 2020 Dec; 3(12):e2029050. PubMed ID: 33301017
[TBL] [Abstract][Full Text] [Related]
20. Prescribing patterns of hydrocortisone in septic shock: a single-center experience of how surviving sepsis guidelines are interpreted and translated into bedside practice.
Contrael KM; Killian AJ; Gregg SR; Buchman TG; Coopersmith CM
Crit Care Med; 2013 Oct; 41(10):2310-7. PubMed ID: 23787398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
